NCT03052751 Study to Test the Safety, Tolerability and Efficacy of UCB7665 in Subjects With Moderate to Severe Myasthenia Gravis Status COMPLETED Phase PHASE2
NCT02965573 A Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of ARGX-113 in Patients With Myasthenia Gravis Who Have Generalized Muscle Weakness Status COMPLETED Phase PHASE2
NCT02774239 A Pilot Trial To Assess The Feasibility And Efficacy Of SCIG In Patients With MG Exacerbation (SCIG-MG) Status COMPLETED Phase PHASE3
NCT02609022 Safety, Tolerability and Immunogenic Response of CV-MG01 in Patients With Myasthenia Gravis Status COMPLETED Phase PHASE1/PHASE2
NCT02473965 Efficacy and Safety of IGIV-C in Corticosteroid Dependent Patients With Generalized Myasthenia Gravis Status COMPLETED Phase PHASE2
NCT02470364 Translation, Cross-cultural Adaptation and Validation of the MGQOL-15-F Status COMPLETED Phase N/A
NCT02317224 The Safety and Efficacy of "3-Hole" Subxiphorid Approach in the Treatment of Anterior Mediastinal Tumor Status UNKNOWN Phase PHASE2
NCT02118805 Innovative Measures of Speech and Swallowing Dysfunction in Neurological Disorders Status COMPLETED Phase N/A
NCT02102594 Therapy of Antibody-mediated Autoimmune Diseases by Bortezomib (TAVAB) Status TERMINATED Phase PHASE2
NCT02100969 Open Label Study of Subcutaneous Immunoglobulin (SCIg) in Myasthenia Gravis Status COMPLETED Phase PHASE2
NCT02066519 Benefits and Tolerance of Exercise in Patients With Generalized and Stabilized Myasthenia Gravis Status COMPLETED Phase NA
NCT01793168 Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford Status RECRUITING Phase N/A
NCT01727193 The Efficacy and Safety of Leflunomide or Azathioprine Therapy in Myasthenia Gravis Patients After Expand Thymectomy Status COMPLETED Phase PHASE3
NCT01555580 A Pilot Study of Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Generalized Myasthenia Gravis Status UNKNOWN Phase EARLY_PHASE1